Reduced smoke-like echo and resolved thrombus in the left atrium with rivaroxaban therapy in an acute cardioembolic stroke patient

Journal of Stroke and Cerebrovascular Diseases

Volumn 23, Issue 6, 2014, Pages 1747-1749

  Saito, Shin ^a   Tomita, Hirofumi ^b   Kimura, Yoshihiro ^b   Shiroto, Hiroshi ^a   Hagii, Joji ^a   Metoki, Norifumi ^a   Hitomi, Hiroyasu ^a   Kamada, Takaatsu ^a   Osanai, Tomohiro ^b   Okumura, Ken ^b   Yasujima, Minoru ^a  

^a Hirosaki Stroke and Rehabilitation Center   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

reduction of a smoke like echo; resolution of a thrombus; Rivaroxaban nonvalvular atrial fibrillation

Indexed keywords

ACETYLSALICYLIC ACID; D DIMER; RIVAROXABAN; THROMBIN ANTITHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 10A INHIBITOR; MORPHOLINE DERIVATIVE; THIOPHENE DERIVATIVE;

AGED; ANTICOAGULANT THERAPY; APHASIA; ARTICLE; BLOOD FLOW VELOCITY; CARDIOEMBOLIC STROKE; CASE REPORT; DIFFUSION WEIGHTED IMAGING; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART LEFT ATRIUM; HEMIPLEGIA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NONVALVULAR ATRIAL FIBRILLATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANKIN SCALE; REHABILITATION CARE; STROKE PATIENT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; DRUG EFFECTS; ECHOGRAPHY; EMBOLISM; HEART ATRIUM; STROKE; THROMBOSIS; TREATMENT OUTCOME;

AGED; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMBOLISM; FACTOR XA INHIBITORS; HEART ATRIA; HUMANS; MALE; MORPHOLINES; STROKE; THIOPHENES; THROMBOSIS; TREATMENT OUTCOME;

EID: 84902547306     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2014.01.014     Document Type: Article

References (13)

1. M. Yasaka, T. Yamaguchi, and T. Miyashita et al. Regression of intracardiac thrombus after embolic stroke Stroke 221 1990 1540 1544
2. S.J. Connolly, M.D. Ezekowitz, and S. Yusuf et al. Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
3. M.R. Patel, K.W. Mahaffey, and J. Garg et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
4. A. Vidal, and G. Vanerio Dabigatran and left atrial appendage thrombus J Thromb Thrombolysis 34 2012 545 547
5. C. Hammerstingl, B. Pötzsch, and G. Nickenig Resolution of giant left atrial appendage thrombus with rivaroxaban Thromb Haemost 109 2013 583 584
6. J. Takasugi, H. Yamagami, and T. Okata et al. Dissolution of the left atrial appendage thrombus with rivaroxaban therapy Cerebrovasc Dis 36 2013 322 323
7. M. Soncini, F. Casazza, and R. Mattioli et al. Hypercoagulability and chronic atrial fibrillation: the role of markers of thrombin generation Minerva Med 88 1997 501 505
8. E. Perzborn, S. Roehrig, and A. Straub et al. Rivaroxaban: a new oral factor Xa inhibitor Arterioscler Thromb Vasc Biol 30 2010 376 381
9. S. Beppu, Y. Nimura, and H. Sakakibara et al. Smoke-like echo in the left atrial cavity in mitral valve disease: its features and significance J Am Coll Cardiol 6 1985 744 749
10. B. Furie, and B.C. Furie Mechanisms of thrombus formation N Engl J Med 359 2008 938 949
11. E. Perzborn, J. Strassburger, and A. Wilmen et al. In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939 - an oral, direct Factor Xa inhibitor J Thromb Haemost 3 2005 514 521
12. R. Varin, S. Mirshahi, and P. Mirshahi et al. Whole blood clots are more resistant to lysis than plasma clots - greater efficacy of rivaroxaban Thromb Res 131 2013 e100 e109
13. M. Hori, M. Matsumoto, and N. Tanahashi et al. Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation - the J-ROCKET AF study Circ J 76 2012 2104 2111